Uterine Transposition with Reitan Ribeiro
IJGC Podcast - A podcast by BMJ Group - Mondays
![](https://is1-ssl.mzstatic.com/image/thumb/Podcasts112/v4/bf/b8/e2/bfb8e2ad-d94e-47c0-3c1d-ea935a9cf3ae/mza_3287283981698921002.jpg/300x300bb-75.jpg)
In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Reitan Ribeiro to discuss uterine transposition. Dr. Ribeiro currently works in the Gynecology Oncology Service in the Department of Surgical Oncology at Erasto Gaertner Hospital in Curitiba, Brazil. He is a member of the IGCS Education Committee and serves as General Secretary of the Brazilian Society of Surgical Oncology (BSSO). Highlights: This prospective study aimed to assess the feasibility of uterine transposition and the result of fertility preservation in a group of non-gynecologic cancer patients post-radiation. Of the eight patients who underwent uterine transposition, the uterus was successfully preserved in six patients; these patients had normal menses, hormonal levels, and vaginal intercourse after the procedure. Three patients attempted to conceive, and two were spontaneously successful, subsequently delivering healthy babies via cesarean section without complications. Uterine transposition could be a feasible option for preserving gonadal and uterine function in patients undergoing pelvic radiotherapy for nongynecological cancer.